Creator's Pride
Looking to invest in the digital creator revolution? This carefully curated collection brings together the companies building the essential tools, platforms, and hardware that power today's creative economy. Our expert analysts have selected stocks positioned to benefit from the growing demand for quality content and creative expression.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
About This Group of Stocks
Our Expert Thinking
The digital creator economy is experiencing explosive growth as more people consume digital media and seek unique content. These companies provide the critical infrastructure - from professional software to global platforms - that enables creators to produce, publish, and profit from their work.
What You Need to Know
This portfolio spans the entire creator ecosystem - industry-standard design software, content distribution platforms, e-commerce marketplaces, and essential hardware. A major catalyst is the integration of AI into creative tools, which is democratizing content creation and expanding the market for these technologies.
Why These Stocks
These companies were selected for their indispensable role in the creative workflow. They represent the backbone of the creator economy - the tools professionals can't work without and the platforms where they build their audiences and businesses. Each company has a strategic position in this growing market.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+42.01%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 42.01% over the next year.
Stocks Rated Buy by Analysts
12 of 15 assets in this group are rated Buy by professional analysts.
Group Growth
This group averaged a 3.7% return last month.
Why You'll Want to Watch These Stocks
AI Is Revolutionizing Creation
AI integration is dramatically expanding these companies' markets by making professional-quality creation accessible to millions of new users. This technological shift could accelerate growth across the portfolio.
The Creator Economy Is Booming
With over 50 million people identifying as creators worldwide, the tools and platforms that power their work are seeing unprecedented demand and engagement. These stocks are at the center of this cultural and economic shift.
Hidden Infrastructure Players
While everyone focuses on the creators themselves, these companies quietly power the entire ecosystem. They're the picks and shovels of the digital content gold rush, positioned to benefit regardless of which creators rise or fall.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Pharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Frequently Asked Questions
Everything you need to know about the product and billing.